OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis
Vijaya Bharti, Reese Watkins, Amrendra Kumar, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111826-111826
Open Access | Times Cited: 26
Vijaya Bharti, Reese Watkins, Amrendra Kumar, et al.
Cell Reports (2022) Vol. 41, Iss. 12, pp. 111826-111826
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Prognostic significance of a signature based on senescence-related genes in colorectal cancer
Zoltán Ungvári, Anna Ungvari, Giampaolo Bianchini, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4495-4504
Open Access | Times Cited: 15
Zoltán Ungvári, Anna Ungvari, Giampaolo Bianchini, et al.
GeroScience (2024) Vol. 46, Iss. 5, pp. 4495-4504
Open Access | Times Cited: 15
Bridging the gap between testing and clinics exploring alternative pre-clinical models in melanoma research
Juliana Santos Rosa Viegas, Bruno Sarmento
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115295-115295
Open Access | Times Cited: 12
Juliana Santos Rosa Viegas, Bruno Sarmento
Advanced Drug Delivery Reviews (2024) Vol. 208, pp. 115295-115295
Open Access | Times Cited: 12
Determinants of p53 DNA binding, gene regulation, and cell fate decisions
Martin Fischer, Morgan A. Sammons
Cell Death and Differentiation (2024) Vol. 31, Iss. 7, pp. 836-843
Open Access | Times Cited: 12
Martin Fischer, Morgan A. Sammons
Cell Death and Differentiation (2024) Vol. 31, Iss. 7, pp. 836-843
Open Access | Times Cited: 12
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Meike Vogler, Yannick Braun, Victoria M. Smith, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Meike Vogler, Yannick Braun, Victoria M. Smith, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Role of the tumor microenvironment in malignant melanoma organoids during the development and metastasis of tumors
Siyu Zhou, Jinghan Lu, Shiyang Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18
Siyu Zhou, Jinghan Lu, Shiyang Liu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18
Therapy-induced senescence as a component of tumor biology: Evidence from clinical cancer
Tareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188994-188994
Closed Access | Times Cited: 18
Tareq Saleh, Sarah Bloukh, Mira Hasan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 188994-188994
Closed Access | Times Cited: 18
Drug-induced senescence by aurora kinase inhibitors attenuates innate immune response of macrophages on gastric cancer organoids
Ruixin Yang, Wingyan Kwan, Yutong Du, et al.
Cancer Letters (2024) Vol. 598, pp. 217106-217106
Open Access | Times Cited: 7
Ruixin Yang, Wingyan Kwan, Yutong Du, et al.
Cancer Letters (2024) Vol. 598, pp. 217106-217106
Open Access | Times Cited: 7
Nurturing longevity through natural compounds: Where do we stand, and where do we go?
Monika N. Todorova, Martina S. Savova, Liliya V. Vasileva, et al.
Food Frontiers (2024) Vol. 5, Iss. 2, pp. 267-310
Open Access | Times Cited: 6
Monika N. Todorova, Martina S. Savova, Liliya V. Vasileva, et al.
Food Frontiers (2024) Vol. 5, Iss. 2, pp. 267-310
Open Access | Times Cited: 6
TTK inhibitor OSU13 promotes immunotherapy responses by activating tumor STING
Vijaya Bharti, Amrendra Kumar, Yinchong Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 15
Open Access | Times Cited: 4
Vijaya Bharti, Amrendra Kumar, Yinchong Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 15
Open Access | Times Cited: 4
Senescence-related genes as prognostic indicators in breast cancer survival
Zoltán Ungvári, Anna Ungvari, Mónika Fekete, et al.
GeroScience (2024)
Open Access | Times Cited: 4
Zoltán Ungvári, Anna Ungvari, Mónika Fekete, et al.
GeroScience (2024)
Open Access | Times Cited: 4
Divergent paths of mammary gland involution: unveiling the cellular dynamics in abruptly and gradually involuted mouse models
Sarmila Majumder, Sanjay Mishra, Neelam Shinde, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Sarmila Majumder, Sanjay Mishra, Neelam Shinde, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Osalmid sensitizes clear cell Renal Cell Carcinoma to navitoclax through a STAT3/BCL-XL pathway
Yizheng Xue, Tianyi Chen, Z. Ma, et al.
Cancer Letters (2025) Vol. 613, pp. 217514-217514
Closed Access
Yizheng Xue, Tianyi Chen, Z. Ma, et al.
Cancer Letters (2025) Vol. 613, pp. 217514-217514
Closed Access
Dual Targeting of Aurora‐A and Bcl‐xL Synergistically Reshapes the Immune Microenvironment and Induces Apoptosis in Breast Cancer
Mingxue Liu, Jing Guo, Weiyong Liu, et al.
Cancer Science (2025)
Open Access
Mingxue Liu, Jing Guo, Weiyong Liu, et al.
Cancer Science (2025)
Open Access
Efficacy and mechanism of iridoid glycosides from Gentianella turkestanorum (Gand.) Holub on non-alcoholic steatohepatitis based on RNA sequencing
Dong-xuan Zheng, Bowei Ju, Li-mei Wen, et al.
Journal of Ethnopharmacology (2025), pp. 119888-119888
Closed Access
Dong-xuan Zheng, Bowei Ju, Li-mei Wen, et al.
Journal of Ethnopharmacology (2025), pp. 119888-119888
Closed Access
Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment
Yulia Aleksandrova, Маргарита Е. Неганова
Antioxidants (2025) Vol. 14, Iss. 2, pp. 199-199
Open Access
Yulia Aleksandrova, Маргарита Е. Неганова
Antioxidants (2025) Vol. 14, Iss. 2, pp. 199-199
Open Access
Mitochondrial priming and response to BH3 mimetics in “one-two punch” senogenic-senolytic strategies
Júlia López, Àngela Llop‐Hernández, Sara Verdura, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Júlia López, Àngela Llop‐Hernández, Sara Verdura, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Synthesis, Characterization, Electrochemical Sensing, DFT Analysis, Molecular Docking and Anticancer Activity of a Novel Thiadiazole-Based Azo Dye Incorporating a Barbituric Acid Scaffold
S. Harisha, Kalyan Nagaraj, Mohan Reddy R, et al.
Journal of Molecular Structure (2025), pp. 142576-142576
Closed Access
S. Harisha, Kalyan Nagaraj, Mohan Reddy R, et al.
Journal of Molecular Structure (2025), pp. 142576-142576
Closed Access
Extractions of aerial parts of Hippomarathrum scabrum with conventional and green methodologies: Chemical profiling, antioxidant, enzyme inhibition, and anti‐cancer effects
Nilofar Nilofar, Tuğçe Duran, Abdullahi İbrahim Uba, et al.
Journal of Separation Science (2023) Vol. 47, Iss. 1
Closed Access | Times Cited: 9
Nilofar Nilofar, Tuğçe Duran, Abdullahi İbrahim Uba, et al.
Journal of Separation Science (2023) Vol. 47, Iss. 1
Closed Access | Times Cited: 9
A Conversation with ChatGPT on Contentious Issues in Senescence and Cancer Research
Ahmed M. Elshazly, Uruk Shahin, Sofian Al Shboul, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 313-327
Open Access | Times Cited: 2
Ahmed M. Elshazly, Uruk Shahin, Sofian Al Shboul, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 5, pp. 313-327
Open Access | Times Cited: 2
Therapy-induced senescence is finally escapable, what is next?
Tareq Saleh
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 713-721
Closed Access | Times Cited: 2
Tareq Saleh
Cell Cycle (2024) Vol. 23, Iss. 6, pp. 713-721
Closed Access | Times Cited: 2
Persister cancer cells are characterized by H4K20me3 heterochromatin that defines a low inflammatory profile
Valentina Ramponi, Laia Richart, Marta Kovatcheva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Valentina Ramponi, Laia Richart, Marta Kovatcheva, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Dual inhibition of KIF11 and BCL2L1 induces apoptosis in lung adenocarcinoma cells
Yuji Sakuma, Sachie Hirai, Toshiyuki Sumi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 678, pp. 84-89
Open Access | Times Cited: 3
Yuji Sakuma, Sachie Hirai, Toshiyuki Sumi, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 678, pp. 84-89
Open Access | Times Cited: 3
Melanocortin receptor 4 as a new target in melanoma therapy: Anticancer activity of the inhibitor ML00253764 alone and in association with B-raf inhibitor vemurafenib
Paola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115952-115952
Open Access | Times Cited: 3
Paola Orlandi, Marta Banchi, Francesca Vaglini, et al.
Biochemical Pharmacology (2023) Vol. 219, pp. 115952-115952
Open Access | Times Cited: 3
Cytotoxic properties of Thuya occidentalis hydroalcoholic extract on androgen unresponsive prostate cancer cells
Gabriela Elisa Hirsch, Mariana Migliorini Parisi, Léo Anderson Meira Martins, et al.
Archives of Physiology and Biochemistry (2024), pp. 1-11
Closed Access
Gabriela Elisa Hirsch, Mariana Migliorini Parisi, Léo Anderson Meira Martins, et al.
Archives of Physiology and Biochemistry (2024), pp. 1-11
Closed Access
Can senolysis be used to overcome tumor immune evasion?
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
Wally Veklych, Thomas E. Ichim, Robert Reznik, et al.
Journal of Stem Cell Research & Therapeutics (2024) Vol. 9, Iss. 1, pp. 26-32
Open Access
